Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup has announced.
Google Ventures and Alphabet (GOOGL.O), an existing investor, also participated in the round.
WHY IT’S IMPORTANT
Top tech companies are racing to position AI-powered offerings as central to their products and services.
Startups catering to the surge in demand for generative
